Ampio Pharmaceuticals, Inc. Email Format

Pharmaceutical ManufacturingColorado, United States2-10 Employees

Ampio Pharmaceuticals, Inc. was a development-stage biopharmaceutical company focused on discovering and developing novel therapies to address inflammatory conditions with limited existing treatments. Based in Englewood, Colorado, the company targeted immunomodulatory approaches aimed at common inflammatory diseases, striving to offer new options where current therapies fall short.

Operating within the pharmaceutical manufacturing sector, Ampio pursued partnerships and leadership in its field, with executive and boardroom changes reported over recent years. The company’s activity included collaboration arrangements, and it announced the termination of an at-the-market equity distribution agreement in early March 2024. Ampio closed its doors on August 16, 2024, marking its exit from development in the biopharmaceutical space.

Sign up for free to view info

Company overview Employee directory